Literature DB >> 3562815

Transcatheter embolization in the management of pulmonary hemorrhage.

J E Rabkin, V I Astafjev, L N Gothman, Y G Grigorjev.   

Abstract

A group of 306 patients with acute pulmonary hemorrhage were evaluated by means of bronchial arteriography and treated with transcatheter embolization. Specific causes for bleeding included lung abscess, chronic pneumonia, tuberculosis, lung cancer, and bronchiectasis. In 120 patients the hemoptysis was massive, with volumes exceeding 500 ml/day. The majority (n = 225) were treated during peak hemorrhage. Embolization was performed with one of three methods: particulate embolization with polyurethane or velour, obturation with the angiographic catheter combined with peripheral embolization by means of infused albumin macroaggregates, and regional infusion of sclerosing agents. Effective hemostasis was obtained initially in 278 patients (90.8%), including 87.5% of those treated during peak hemorrhage. In 26 of 28 cases without initial response, the pulmonary artery was the source of bleeding. Recurrent bleeding, within 1-4 days, requiring surgery was observed in 39 patients with initially successful hemostasis. Of 158 patients who were treated without surgery, subsequent episodes of hemoptysis occurred in 36. Combined methods of embolization may improve the efficacy of treatment of operable and inoperable patients with lung disease complicated by hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3562815     DOI: 10.1148/radiology.163.2.3562815

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  41 in total

1.  BRONCHIAL ARTERIOGRAPHY AND TRANSCATHETER EMBOLIZATION IN MANAGEMENT OF SEVERE HAEMOPTYSIS.

Authors:  C Mohan; K V Sangameswaran; Bnbm Prasad; G S Sabhikhi; J D'Souza
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Bronchial artery embolization for hemoptysis.

Authors:  David R Sopko; Tony P Smith
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

3.  Massive hemoptysis from a pulmonary sequestration controlled by embolization of aberrant pulmonary arteries: case report.

Authors:  K Hayakawa; T Soga; K Hamamoto; S Kawarazaki; M Mitsumori
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Nov-Dec       Impact factor: 2.740

4.  Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis.

Authors:  I L Tonkin; A S Hanissian; T F Boulden; S L Baum; M L Gavant; R E Gold; P George; W J Green
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jul-Aug       Impact factor: 2.740

5.  64-detector row CT evaluation of bronchial and non-bronchial systemic arteries in life-threatening haemoptysis.

Authors:  I Ponnuswamy; S T Sankaravadivelu; P Maduraimuthu; K Natarajan; B P Sathyanathan; S Sadras
Journal:  Br J Radiol       Date:  2012-05-17       Impact factor: 3.039

6.  Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis.

Authors:  Joo-Young Chun; Anna-Maria Belli
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

Review 7.  Massive haemoptysis.

Authors:  D K Jones; R J Davis
Journal:  BMJ       Date:  1990-04-07

8.  Bronchial artery embolization for malignant hemoptysis: a single institutional experience.

Authors:  Amar S Mehta; Osman Ahmed; Danial Jilani; Steve Zangan; Jonathan Lorenz; Brian Funaki; Thuong Van Ha; Rakesh Navuluri
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

9.  Embolotherapy for persistent hemoptysis: the significance of pleural thickening.

Authors:  S Tamura; T Kodama; N Otsuka; Y Kihara; K Nisikawa; Y Yuki; M Samejima; O Uwada; K Watanabe; S Minoda
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Mar-Apr       Impact factor: 2.740

10.  The effectiveness of embolotherapy for treatment of hemoptysis in patients with varying severity of tuberculosis by assessment of chest radiography.

Authors:  Woocheol Kwon; Young Ju Kim; Young Han Lee; Won-Yeon Lee; Myung Soon Kim
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.